Unequal Access to Cancer Drugs in Europe: A Call for Action

The video discusses a report on the unequal distribution of cancer drugs in Europe. Dr. Nils Wickling presented findings at the European Parliament, highlighting that Austria, Spain, and Switzerland receive new drugs first, while the UK, Czech Republic, Hungary, and Poland are often excluded. This situation presents a challenge for the European Union Agency (EUA) to address these disparities.

Who is Doctor Nils Wickling and what role did he play in the study?

How do patients in the UK, Czech Republic, Hungary, and Poland compare to those in Austria, Spain, and Switzerland regarding access to new drugs?